as on November 4, 2025 at 4:01 pm IST
Day's High
3.85%
Upside
52 Week's Low
52 Week's High
57.87%
Downside
10.87%
Upside
as on November 4, 2025 at 4:01 pm IST
Market Cap
₹76.02 Cr
Return on Equity (ROE)
0.56
PE Ratio (TTM)
-19.16
Return on capital employed (ROCE)
0.84
Industry PE ratio
42.27
Beta (LTM)
0.4
P/B Ratio
1.51
Dividend Yield
0PEG Ratio
-14.09
Quarterly Earnings Growth YOY
-142.86
EPS (TTM)
-2.5
Sector
Pharmaceuticals
Book Value
9.14
Technical Analysis
Bullish
View Technical Analysis
as on November 4, 2025 at 4:01 pm IST
Novelix Pharmaceuticals Ltd in the last 5 years
Lowest (-38.24x)
January 31, 2018
Today (-19.16x)
November 4, 2025
Industry (42.27x)
November 4, 2025
Highest (-1.18x)
September 29, 2021
Today’s Price to Earnings Ratio: -19.16x
Compare market cap, revenue, PE, and other key metrics of Novelix Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 76.02 | 130% | 0.00 | -3 | 8 | |
| BUY | 21,807.79 | 42.13% | 0.76 | 374 | 2,908 | |
| NA | 260.80 | 437.54% | 0.61 | 8 | 70 | |
| NA | 64.33 | 26.94% | 0.00 | 4 | 113 | |
| BUY | 15,017.62 | 58.47% | 0.51 | 160 | 1,006 |
Search interest for Novelix Pharmaceuticals Ltd Stock has increased by 207% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:207% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Novelix Pharmaceuticals Ltd.
Novelix Pharmaceuticals Ltd’s net profit fell -140.63% since last year same period to ₹0.13Cr in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -85.71% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2012, Novelix Pharmaceuticals Ltd has declared dividend of ₹0.30 per share on 23 Jul 2012 - translating a dividend yield of 1.15%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
![]()
Promoters have increased holdings from 52.75% to 53.33% in Sep 2025 quarter
Price Rise
![]()
In the last 1 month, Novelix Pharma. stock has moved up by 30.6%
Best in 1 Year
![]()
In the last 1 year, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers
Best in 3 Years
![]()
In the last 3 years, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers
Retail Holding Down
![]()
Retail Investor have decreased holdings from 47.25% to 46.67% in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.43 Cr → 1.3 Cr (in ₹), with an average decrease of 9.1% per quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, -0.07 Cr → -0.13 Cr (in ₹), with an average decrease of 85.7% per quarter
| Organisation | Novelix Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Novelix Pharmaceuticals Ltd share price today stands at ₹52 as on at the close of the market. Novelix Pharmaceuticals Ltd share today touched a day high of ₹54 and a low of ₹52.
Novelix Pharmaceuticals Ltd touched a 52 week high of ₹57.65 and a 52 week low of ₹21.91. Novelix Pharmaceuticals Ltd share price today i.e. is closed at ₹52, which is -9.80% down from its 52 week high and 137.33% up from its 52 week low.
Novelix Pharmaceuticals Ltd market capitalisation is ₹76.02 Cr as on .
To buy Novelix Pharmaceuticals Ltd shares, you need to follow these steps:
Novelix Pharmaceuticals Ltd trading volume is 16.94K as on . This means that 16.94K shares of Novelix Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.